Holoeyes Welcomes Digital Marketing Pioneer Kyoichi Yokota as Advisor

Holoeyes Appoints Kyoichi Yokota as Advisor

Holoeyes Inc., headquartered in Minato City, Tokyo, has made a significant strategic move to enhance its presence in the pharmaceutical industry by appointing Kyoichi Yokota as an advisor effective July 1, 2025. Yokota is recognized for his extensive knowledge and experience in digital marketing and digital transformation (DX) within the pharmaceutical and healthcare sectors. His journey has been marked by a focused commitment to pushing digital transformation initiatives in pharmaceutical companies and reforming the information exchange points with healthcare professionals.

Yokota has an impressive background in various fields, currently engaging in activities ranging from physician platform business development to pharmaceutical marketing support, media content production, and running cross-industry communities. His deep understanding of the industry and his ability to bridge technology and healthcare make him a valuable asset to Holoeyes.

Holoeyes, well-known for its innovative use of 3D and VR technology in surgical assistance and medical education, seeks to enhance its collaborative strategies with pharmaceutical companies and hospital groups. The company aims to leverage Yokota's expertise to accelerate the implementation of digital solutions in healthcare settings, thus driving tangible improvements in the industry.

Comments from Kyoichi Yokota

Mr. Yokota expressed his enthusiasm about joining Holoeyes, stating, "Holoeyes stands out as a unique entity that is revolutionizing visual experiences in healthcare, seamlessly supporting processes from preoperative planning to education and collaboration. I am thrilled to contribute to the innovative endeavors that bridge the gap between the pharmaceutical industry, healthcare, and XR technology, focusing on enhancing experience value and promoting widespread adoption."

Comments from Holoeyes CEO Maki Sugimoto

Maki Sugimoto, the CEO of Holoeyes, warmly welcomed Yokota's appointment, noting, "I am genuinely pleased to have Mr. Yokota, a highly respected name in the medical field and someone I have relied on since before Holoeyes was founded, join us as an advisor. His rich knowledge in digital marketing, XR technology implementation, and DX will be instrumental in realizing our vision. With his guidance, we are committed to accelerating the sophistication of our business and enhancing our social impact with greater speed and effectiveness."

Holoeyes aims to contribute positively to the future of medicine and society by working with diverse and innovative talent, ensuring the integration of expertise and creativity in every aspect of their operations.

Kyoichi Yokota's Profile

Kyoichi Yokota graduated from Kyoto Prefectural University with a degree in agriculture and joined Sumitomo Dainippon Pharma Co., Ltd. (now known as Sumitomo Pharma Co., Ltd.). After 14 years as a medical representative, he transitioned through several key positions, including academic liaison and branch manager, eventually founding a media strategy organization in the marketing department in 2007 to promote digital marketing across the company. He took on further roles as the head of the IT department, senior digital officer, and leader of the MarTech strategy promotion office, driving overall DX initiatives at the company. In April 2020, he became a visiting professor at Tohoku University. Presently, he is actively engaged in digital transformation efforts within the pharmaceutical and healthcare sectors, particularly at physician community platforms.

About Holoeyes

Holoeyes Inc. specializes in developing and providing VR/AR platforms that utilize 3D medical data. The company is at the forefront of clinical implementations in areas such as preoperative simulation, education for medical students and residents, and support for informed consent processes with patients. By collaborating with various university hospitals and medical institutions, Holoeyes is pushing forward the social implementation of medical applications in the XR field.